Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.

Jaime-Pérez, José Carlos

Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma. [electronic resource] - Archives of medical research Aug 2015 - 454-61 p. digital

Publication Type: Journal Article

1873-5487

10.1016/j.arcmed.2015.07.004 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cohort Studies
Disease-Free Survival
Female
Humans
Lymphoma, Follicular--drug therapy
Lymphoma, Large B-Cell, Diffuse--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Prognosis
Retrospective Studies
Risk Factors
Rituximab--administration & dosage
Treatment Outcome
Young Adult